Tomohira
Yuso Tomohira, Osaka JP
Patent application number | Description | Published |
---|---|---|
20110071084 | BENZAZEPINE DERIVATIVES USEFUL AS VASOPRESSIN ANTAGONISTS - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 03-24-2011 |
20140024619 | Benzazepine Derivatives Useful as Vasopressin Antagonists - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 01-23-2014 |
20140024640 | Benzazepine Derivatives Useful as Vasopressin Antagonists - The present invention provides a benzazepine compound that can maintain for a long period of time the blood level of tolvaptan enabling to provide the desired pharmaceutical effects. The benzazepine compound of the present invention is represented by general formula (1) | 01-23-2014 |
Yuso Tomohira, Tokushima-Shi JP
Yuso Tomohira, Tokushima JP
Patent application number | Description | Published |
---|---|---|
20090047357 | METHOD OF PRODUCING DRUG-CONTAINING WAX MATRIX PARTICLES, EXTRUDER TO BE USED IN THE METHOD AND SUSTAINED-RELEASE PREPARATION CONTAINING CILOSTAZOL - The present invention aims to provide a method for producing, by a simple method, drug-containing wax matrix granules, particularly drug-containing wax matrix granules having an average particle diameter of 1 mm or lower, while avoiding liquid blockage due to the recrystallization of a molten drug during the period from a melting step to a spray step. | 02-19-2009 |
Yuso Tomohira, Tokushima-Ken JP
Patent application number | Description | Published |
---|---|---|
20160101183 | AQUEOUS OPHTHALMIC SUSPENSION OF CRYSTALLINE REBAMIPIDE - The invention provides an ophthalmic product containing rebamipide, which has a transparency enough to be agreeable feeling on using it and has neutral so weakly acidic pH not to injury of the keratoconjunctiva of a patient suffering from dry eye. An aqueous suspension of crystalline rebamipide which has an improved transparency is provided by adding an aqueous solution of rebamipide dissolved by a base such as sodium hydroxide or an aqueous solution of a salt of rebamipide to an aqueous acidic solution such as hydrochloric acid containing at least one of the compounds selected from water-soluble polymers and surfactants, and mixing them. | 04-14-2016 |